Correlation Between Acumen Pharmaceuticals and NioCorp Developments
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and NioCorp Developments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and NioCorp Developments into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and NioCorp Developments Ltd, you can compare the effects of market volatilities on Acumen Pharmaceuticals and NioCorp Developments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of NioCorp Developments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and NioCorp Developments.
Diversification Opportunities for Acumen Pharmaceuticals and NioCorp Developments
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Acumen and NioCorp is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and NioCorp Developments Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NioCorp Developments and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with NioCorp Developments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NioCorp Developments has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and NioCorp Developments go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and NioCorp Developments
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the NioCorp Developments. But the stock apears to be less risky and, when comparing its historical volatility, Acumen Pharmaceuticals is 1.69 times less risky than NioCorp Developments. The stock trades about -0.3 of its potential returns per unit of risk. The NioCorp Developments Ltd is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 185.00 in NioCorp Developments Ltd on November 28, 2024 and sell it today you would earn a total of 25.50 from holding NioCorp Developments Ltd or generate 13.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Acumen Pharmaceuticals vs. NioCorp Developments Ltd
Performance |
| Timeline |
| Acumen Pharmaceuticals |
| NioCorp Developments |
Acumen Pharmaceuticals and NioCorp Developments Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acumen Pharmaceuticals and NioCorp Developments
The main advantage of trading using opposite Acumen Pharmaceuticals and NioCorp Developments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, NioCorp Developments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NioCorp Developments will offset losses from the drop in NioCorp Developments' long position.| Acumen Pharmaceuticals vs. Beam Therapeutics | Acumen Pharmaceuticals vs. Editas Medicine | Acumen Pharmaceuticals vs. Caribou Biosciences | Acumen Pharmaceuticals vs. Verve Therapeutics |
| NioCorp Developments vs. Volaris | NioCorp Developments vs. Universal Music Group | NioCorp Developments vs. LATAM Airlines Group | NioCorp Developments vs. PACCAR Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |